Maravai Lifesciences Holdings (MRVI) Total Current Liabilities (2020 - 2026)

Maravai Lifesciences Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $42.6 million for Q1 2026.

• In Q1 2026, Total Current Liabilities fell 32.52% year-over-year to $42.6 million; the TTM figure through Mar 2026 stood at $42.6 million (down 32.52% YoY), while the FY2025 annual figure was $44.9 million, down 21.16% from the prior year.
• Total Current Liabilities was $42.6 million for Q1 2026 at Maravai Lifesciences Holdings, down from $44.9 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $124.9 million in Q1 2023 to a low of $42.6 million in Q1 2026.
• Historically, Total Current Liabilities has averaged $77.7 million across 5 years, with a median of $69.7 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Total Current Liabilities surged 44.1% in 2023, then slumped 52.74% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $110.1 million in 2022, then retreated by 20.59% to $87.5 million in 2023, then tumbled by 34.87% to $57.0 million in 2024, then decreased by 21.16% to $44.9 million in 2025, then fell by 5.11% to $42.6 million in 2026.
• The last three Total Current Liabilities figures came in at $42.6 million (Q1 2026), $44.9 million (Q4 2025), and $61.6 million (Q3 2025), per Business Quant data.